In 1962 and 1963 Professor Riccabona worked with a scholarship at the Massachusetts General Hospital in Boston, USA, where under Professor John B. Stanbury he got particularly familiar with thyroid diagnoses using radioactive isotopes.
After returning to the Hospital at Innsbruck, Professor Riccabona finished his specialist registrar in Surgery in 1965, but his heart already belonged to Nuclear Medicine.
In 1964, the first outpatient service for the diagnosis and treatment of thyroid diseases was set up at the Hospital in Innsbruck, and the first gamma camera was purchased in Austria. The range of Nuclear Medicine examinations was then extended to liver, kidney, brain, spleen, lung, as well as skeletal diagnosis, and the in vitro tests were further established.
In 1968, Professor Riccabona received his post-doctoral lecturing qualification with the title BThe Endemic Struma in Tyrol^, in the subject BSurgery with Special Consideration of the Isotope Application^. In the same year, the Isotope Outpatient Service moved to the basement of the Surgery building, where it is still located today. To this day, not only the Thyroid Outpatient Clinic, but also the Conventional Nuclear Medicine Clinic and the PET-Centre with two PET/ CTs have been installed.
Furthermore, in 1969, the first Nuclear Medicine Therapy Ward in Austria for high-dose radionuclide therapies was put into operation, located on the first floor of the Surgical building, which was expanded and renewed in 2003 with 13 treatment beds.
In 1976 I would like to mention an anecdote on the occasion of the 80th birthday of Professor Riccabona: Emeritus Professer Rudolf Höfer from Vienna University, at over 90 years of age, was invited for the Annual Tyrolean Nuclear Medicine Congress in Innsbruck and travelled alone by train. In his speech, Professor Höfer mentioned both the East (Vienna) and the West (Innsbruck) of Nuclear Medicine in Austria in a positive light, pointing to the controversial discussions and differences-not to say the long-lasting competitionbetween both institutions and presenting to Professor Riccabona a self-made birthday cake, as a small gesture of final peace (Figs. 1 and 2) .
Not only for his scientific engagement but also following participation in numerous IAEA projects, Professor Riccabona became well known around the world, especially in the field of thyroid diseases. In 2015, for his life-long pioneering work, Professor Riccabona received the Lifetime Achievement Award from the World Association of Radionuclide Therapy (WARMTH), which also included the honorary membership of WARMTH.
Professor Riccabona has always been very ambitious to raise funds for the clinic and science. He was one of the first Nuclear Medicine physicians who, in 1995-1996, paid for his work on BEndemic Struma^with an NIH grant.
I am proud to direct the Department of Nuclear Medicine at the Medical University of Innsbruck, which I have done for the last 15 years since the retirement of Professor Georg Riccabona, and where we have one of the largest teams in Europe that continues to focus on Nuclear Medicine therapy, which is now experiencing its renaissance. Targeted therapy has its historical origin in thyroid carcinoma therapy with radioiodine, iodine 131, the first model of precision medicine that Professor Riccabona introduced so successfully in Austria.
Professor Riccabona passed away on January 13, 2019. He left behind his wife, Dorothea Felicitas Riccabona, to whom he was married since 1956, and also five children, 15 grandchildren and several great-grandchildren.
Professor Riccabona's hobbies were painting, hiking and gardening.
With him the EANM loses not only one of its cofounders, but also an outstanding pioneer of Nuclear Medicine.
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